Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Peter Jaehnig"'
Autor:
Carsten-Henning Ohlmann, Michelle Jäschke, Peter Jaehnig, Susane Krege, Jürgen Gschwend, Heidrun Rexer, Michael Stöckle
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-9 (2017)
Abstract Background The value of continuation of luteinizing hormone-releasing hormone (LHRH) therapy in castration-resistant prostate cancer (CRPC) remains controversial and clear evidence is lacking. Argumentation for cessation of LHRH therapy is t
Externí odkaz:
https://doaj.org/article/690cf09f4623408381878b95f241dadc
Autor:
Carsten-Henning Ohlmann, Michelle Jäschke, Peter Jaehnig, Susanne Krege, Jürgen Gschwend, Heidrun Rexer, Kerstin Junker, Roger Zillmann, Christoph Rüssel, Eva Hellmis, Henrik Suttmann, Martin Janssen, Jan Marin, Andreas Hübner, Michael Mathers, Jochen Gleißner, Michael Scheffler, Susan Feyerabend, Jens Telle, Jörg Klier, Michael Stöckle
Background Although the benefit of androgen deprivation therapy (ADT) continuation in metastatic castration-resistant prostate cancer (mCRPC) remains controversial, clinical evidence is lacking. Recent results indicated that treatment with abirateron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e19dd991763bf7d9060ca36a498e3b
Autor:
Zenaida Mojares, Peter Richmond, Sepehr Shakib, Sharon E. Frey, Bikash Verma, Timothy W. Smith, Matthew Hohenboken, Claudia Kittel, Peter Jaehnig, Terapong Tantawichien, Pornthep Chanthavanich, Niranjan Kanesa-thasan
Publikováno v:
Open Forum Infectious Diseases
Background A/H5N1 influenza viruses have high pandemic potential; consequently, vaccines need to be produced rapidly. MF59® adjuvant reduces the antigen required per dose, allowing for dose sparing and more rapid vaccine availability. Methods Two mu
Autor:
Shelly Senders, Peter Jaehnig, Richard de Rooij, Richa Chandra, Terry Nolan, Tawee Chotpitayasunondh, Simon Carson, Maria Rosario Capeding
Publikováno v:
Vaccine. 34(2):230-236
BackgroundCell culture-derived inactivated influenza vaccines (TIVc) are necessary for scale and predictability of production to meet global demand. This study compared the safety and tolerability of TIVc with an egg-derived trivalent influenza vacci
Publikováno v:
The Journal of Infectious Diseases. 212:72-80
A/H3N2 variant (H3N2v) swine influenza virus containing the matrix (M) gene from the 2009 A/H1N1 pandemic virus was first identified in pigs in 2010 and subsequently detected in 12 people in the United States in 2011 [1]. The following year, 309 conf
Autor:
Jürgen E. Gschwend, Michelle Jäschke, Peter Jaehnig, Carsten-Henning Ohlmann, Heidrun Rexer, Michael Stöckle, Susane Krege
Publikováno v:
Trials
Trials, Vol 18, Iss 1, Pp 1-9 (2017)
Trials, Vol 18, Iss 1, Pp 1-9 (2017)
Background The value of continuation of luteinizing hormone-releasing hormone (LHRH) therapy in castration-resistant prostate cancer (CRPC) remains controversial and clear evidence is lacking. Argumentation for cessation of LHRH therapy is the prolon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d742b887e3018b3109a943d8cf2464db
https://www.ncbi.nlm.nih.gov/pubmed/28978327
https://www.ncbi.nlm.nih.gov/pubmed/28978327
Autor:
Jacqueline, Detert, René, Dziurla, Paula, Hoff, Timo, Gaber, Pascal, Klaus, Hans, Bastian, Tanja, Braun, Saskia, Schellmann, Thomas, Penzel, Ingo, Fietze, Peter-Andreas, Loeschmann, Peter, Jaehnig, Rainer H, Straub, Gerd R, Burmester, Frank, Buttgereit
Publikováno v:
Clinical and experimental rheumatology. 34(5)
To compare sleep quality, disease activity and patient-reported outcomes such as fatigue and immune parameters in patients with rheumatoid arthritis treated with etanercept (ETA) or methotrexate (MTX).Of 36 patients (28-joint Disease Activity Score,
Autor:
William R.G. Gibb, C. David Marsden, Sarah Rose, Masahiro Nomoto, E.Amanda Jackson, Peter Jenner, Peter Jaehnig
Publikováno v:
European journal of pharmacology. 230(2)
The effect of treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on juvenile (6-8 months), young adult (2-4 years) and aged (8-10 years) common marmosets were compared. Juvenile marmosets were more resistant to the actions of MPTP and
Autor:
Malloy, Amanda
Publikováno v:
Amstat News. Mar2024, Issue 561, p16-20. 5p.
Publikováno v:
Amstat News. Mar2023, Issue 549, p23-26. 4p.